María Edith González-Serrano

María Edith González-Serrano

Auto-generated profile, based on publicly available information

María Edith González-Serrano

Instituto Nacional de Pediatria 28 Immunodeficiencies Laboratory Mexico City

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in World Allergy Organization Journal
Verified
Journal Article
Open access
ZEZeinab A. El-Sayed
Zeinab A. El-Sayed
IAIrina Abramova
Irina Abramova
JAJuan Carlos Aldave
Juan Carlos Aldave
WAWaleed Al-Herz
Waleed Al-Herz
LBLiliana Bezrodnik
Liliana Bezrodnik
KSKathleen E. Sullivan
Kathleen E. Sullivan
X-linked agammaglobulinemia is an inherited immunodeficiency recognized since 1952. In spite of seven decades of experience, there is still a limited understanding of regional differences in presentation and complications. This study was designed by the Primary Immunodeficiencies Committee of the World Allergy Organization to better understand regional needs, challenges and unique patient features. A survey instrument was designed by the Primary Immunodeficiencies Committee of the World Allergy Organization to collect both structured and semi-structured data on X-linked agammaglobulinemia. The survey was sent to 54 centers around the world chosen on the basis of World Allergy Organization participation and/or registration in the European Society for Immunodeficiencies. There were 40 centers that responded, comprising 32 countries. This study reports on 783 patients from 40 centers around the world. Problems with diagnosis are highlighted by the reported delays in diagnosis>24 months in 34% of patients and the lack of genetic studies in 39% of centers Two infections exhibited regional variation. Vaccine-associated paralytic poliomyelitis was seen only in countries with live polio vaccination and two centers reported mycobacteria. High rates of morbidity were reported. Acute and chronic lung diseases accounted for 41% of the deaths. Unusual complications such as inflammatory bowel disease and large granular lymphocyte disease, among others were specifically enumerated, and while individually uncommon, they were collectively seen in 20.3% of patients. These data suggest that a broad range of both inflammatory, infectious, and autoimmune conditions can occur in patients. The breadth of complications and lack of data on management subsequently appeared as a significant challenge reported by centers. Survival above 20 years of age was lowest in Africa (22%) and reached above 70% in Australia, Europe and the Americas. Centers were asked to report their challenges and responses (n = 116) emphasized the difficulties in access to immunoglobulin products (16%) and reflected the ongoing need for education of both patients and referring physicians. This is the largest study of patients with X-linked agammaglobulinemia and emphasizes the continued morbidity and mortality of XLA despite progress in diagnosis and treatment. It presents a world view of the successes and challenges for patients and physicians alike. A pivotal finding is the need for education of physicians regarding typical symptoms suggesting a possible diagnosis of X-linked agammaglobulinemia and sharing of best practices for the less common complications.

14 February 2024 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
ELEduardo Liquidano‐Perez
Eduardo Liquidano‐Perez
GMGibert Maza‐Ramos
Gibert Maza‐Ramos
BABethy Alexandra Perez Arias
Bethy Alexandra Perez Arias
SRSaúl Oswaldo Lugo Reyes
Saúl Oswaldo Lugo Reyes
TBTania Barragán-Arévalo
Tania Barragán-Arévalo
MGMaria Edith Gonzalez‐Serrano
Maria Edith Gonzalez‐Serrano

21 February 2023 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
ECElizabeth Alejandra De la Cruz Córdoba
Elizabeth Alejandra De la Cruz Córdoba
JMJuan Antonio González Medrano
Juan Antonio González Medrano
PMPatricia Herrera Mora
Patricia Herrera Mora
GGGilberto Gómez-Garza
Gilberto Gómez-Garza
MGMaría Edith González-Serrano
María Edith González-Serrano
CCCarmen Alicia Correa-Ramírez
Carmen Alicia Correa-Ramírez

6 October 2025 in Journal of Human Immunity
Verified
Journal Article
Open access
TOTiago Santos de Oliveira
Tiago Santos de Oliveira
RSRanieri Coelho Salgado
Ranieri Coelho Salgado
LGLillian Nunes Gomes
Lillian Nunes Gomes
CSCarolina Sánchez-Rodríguez
Carolina Sánchez-Rodríguez
JFJanáira Fernandes Severo Ferreira
Janáira Fernandes Severo Ferreira
ACAntonio Condino-Neto
Antonio Condino-Neto
Chronic granulomatous disease (CGD) is an inborn error of immunity (IEI) caused by mutations in genes encoding components of the NADPH oxidase complex, leading to defective microbial killing and increased susceptibility to infections. This study analyzed clinical, genetic, and geospatial data from 238 CGD patients across eight Latin American countries. Genetic variants were identified in 141 patients (59%), with XL-CGD being the most common form (77%). Pneumonia (80%), lymphadenopathy (63%), and skin infections (55.5%) were frequent, with bacteria and fungi, such as Staphylococcus aureus, Aspergillus spp., and mycobacteria, as major pathogens. Antimicrobial prophylaxis was widely used, while IFN-γ was mainly prescribed in Mexico, mainly in cases of classic CGD (XL-CGD). Hematopoietic stem cell transplantation (HSCT) did not improve survival compared to prophylaxis. The leading cause of death was infection, particularly pneumonia and sepsis. XL-CGD patients had worse survival outcomes. The study highlights the need for improved genetic diagnosis, newborn screening, regional treatment guidelines, and expanded access to HSCT.

10 June 2022 in Revista Alergia México
Verified
Journal Article
Open access
PDF file
ELEduardo Liquidano-Pérez
Eduardo Liquidano-Pérez
GMGibert Maza-Ramos
Gibert Maza-Ramos
MYMarco Yamazaki-Nakashimada
Marco Yamazaki-Nakashimada
TBTania Barragán-Arévalo
Tania Barragán-Arévalo
SRSaúl Oswaldo Lugo Reyes
Saúl Oswaldo Lugo Reyes
MGMaría Edith González-Serrano
María Edith González-Serrano
La inmunodeficiencia combinada (IDC) por deficiencia de DOCK8 es un error innato de la inmunidad, caracterizado por alteración en linfocitos T y B; el espectro de manifestaciones incluye alergia, autoinmunidad, inflamación, predisposición a cáncer e infecciones recurrentes. La deficiencia de DOCK8 se puede distinguir de otras IDC o dentro del espectro de síndromes de hiper-IgE porque presenta una profunda susceptibilidad a las infecciones virales de la piel, con cánceres de piel asociados y alergias alimentarias graves. El locus subtelomérico 9p24.3, donde se ubica DOCK8, incluye numerosos elementos repetitivos de secuencia que predisponen a la generación de grandes deleciones de la línea germinal, así como a la reparación del ADN somático, mediada por recombinación. La producción residual de la proteína DOCK8 contribuye al fenotipo variable de la enfermedad. Las infecciones virales graves de la piel y la vasculopatía asociada a virus de la varicela Zóster (VVZ) reflejan una función importante de la proteína DOCK8, que normalmente se requiere para mantener la integridad de los linfocitos a medida que las células migran a través de tejidos. La pérdida de DOCK8 provoca deficiencias inmunitarias a través de otros mecanismos, incluido un defecto de supervivencia celular. Existen alteraciones en la respuesta de las células dendríticas, lo que explica la susceptibilidad a infección por virus, así como en los linfocitos T reguladores que podrían ayudar a explicar la autoinmunidad en los pacientes. El trasplante de células hematopoyéticas pluripotenciales es por el momento el único tratamiento curativo, mejora el eccema, la alergia y la susceptibilidad a infecciones.

30 June 2023 in Población y Salud en Mesoamérica
Verified
Journal Article
Open access
PDF file
QMQuezada Ugalde Ana María
Quezada Ugalde Ana María
MHMelisa Edith Valverde Hernández
Melisa Edith Valverde Hernández
SSSunny González Serrano
Sunny González Serrano
Introduction: The General Test for the Evaluation of the Integral Development of the Child (EDIN-II) created and validated in Costa Rica, classifies the child population with normal or age-appropriate development (green), with a developmental lag (yellow), or else, with a risk of significant delay (red). However, the results of its application at the population level are not known. The aim of this article is to report the level of development of the infants evaluated during the validation processes of the EDIN-II test. Methodology: A secondary analysis of descriptive and correlational scope is carried out; the EDIN-II test was applied by nursing professionals, during the years 2016 - 2020. A total of 438 children aged 1 to 72 months in different zones of the metropolitan area of the country. Results: 78.5 % (n= 344) have an adequate development for their age and 21.5 % (n= 94) present a delay or risk of delay in their development. Conclusions: The prevalence of risk of developmental delay was 21.5%, with a higher proportion between 12 and 36 months of life.